Genefron Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Liquidation

Genefron General Information

Description

Developer of genomic-based diagnostic tests designed for predicting treatment response and disease prognosis. The company analyzes gene expression data, applies artificial intelligence methods, evaluates immune system-related markers, and processes patient-specific biological information to assess treatment suitability and disease progression in autoimmune and viral conditions, enabling healthcare providers and clinical researchers to support treatment selection and patient monitoring based on molecular data.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Corporate Office
  • Studio Building
  • Floor 1, Neve Ilan
  • Jerusalem 9085100
  • Israel
Primary Industry
Other Healthcare Technology Systems
Other Industries
Diagnostic Equipment
Decision/Risk Analysis
Corporate Office
  • Studio Building
  • Floor 1, Neve Ilan
  • Jerusalem 9085100
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genefron Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 06-Jun-2023 Completed Bankruptcy: Liquidation
1. Angel (individual) Completed Startup
To view Genefron’s complete valuation and funding history, request access »

Genefron Patents

Genefron Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3755810-A1 Methods of determining response to tnf alpha blockers Inactive 19-Feb-2018
EP-3755810-A4 Methods of determining response to tnf alpha blockers Inactive 19-Feb-2018
US-20200399698-A1 Methods of determining response to tnf alpha blockers Inactive 19-Feb-2018
WO-2019159186-A1 Methods of determining response to tnf alpha blockers Inactive 19-Feb-2018
US-20180305761-A1 Methods and kits for prediction and diagnosis of human cytomegalovirus (hcmv) congenital transmission Inactive 09-Oct-2015 C12Q1/6883
To view Genefron’s complete patent history, request access »

Genefron Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genefron FAQs

  • When was Genefron founded?

    Genefron was founded in 2011.

  • Where is Genefron headquartered?

    Genefron is headquartered in Jerusalem, Israel.

  • What is the size of Genefron?

    Genefron has 3 total employees.

  • What industry is Genefron in?

    Genefron’s primary industry is Other Healthcare Technology Systems.

  • Is Genefron a private or public company?

    Genefron is a Private company.

  • What is Genefron’s current revenue?

    The current revenue for Genefron is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process